Oaktree Acquisition Corp. Iii Life Sciences · NASDAQ:OACC
Barclays PLC's stake in Oaktree Acquisition Corp. Iii Life Sciences fell to 4.35% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 11, 2026
Barclays PLC's stake in Oaktree Acquisition Corp. Iii Life Sciences fell to 4.35%, 861,625 shares, as a passive investor on Dec 31, 2025. Filed Feb 11, 2026 (Schedule 13G/A).
- Stake
- 4.35%
- Shares
- 861,625
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Barclays PLC | 4.35% | 861,625 |
Source
Related
- Oaktree Acquisition Corp. Iii Life Sciences
- Barclays PLC
- Oaktree Acquisition Corp. Iii Life Sciences shareholders
- Schedule 13G · Barclays PLC · Aug 13, 2026
- Schedule 13G · Barclays PLC · May 13, 2025
- Schedule 13G · Decagon Asset Management LLP · Aug 14, 2026
- Schedule 13G · Fort Baker Capital Management LP · May 15, 2026
- Schedule 13G · Goldman Sachs Group Inc · May 11, 2026
- Schedule 13G/A · Goldman Sachs Group Inc · Aug 12, 2025
- Schedule 13G/A · Millennium Management LLC · Jul 15, 2025